About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Route 92 Medical Appoints Medtech Industry Veterans Mitch Hill and Lucas Buchanan to its Board of Directors

By: via GlobeNewswire

SAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the election of Mitch Hill and Lucas Buchanan to its Board of Directors. The appointment of these industry veterans will bring critical operational and financial experience to the Route 92 Medical Board of Directors as the company continues to commercialize its differentiated portfolio of neurovascular solutions.

Mr. Hill is a seasoned healthcare executive with a strong track record of guiding high-growth, venture-backed companies through key inflection points in the corporate life cycle. Most recently, he served as Senior Business Advisor and Chief Financial Officer of Inari Medical, where he was instrumental in the company’s rapid expansion and eventual $4.9 billion acquisition by Stryker Medical. Before joining Inari, he served as Chief Financial Officer for a number of technology, medical device, and healthcare services companies. He also serves on the Board of Directors for CVRx, Inc. and The Glaucoma Foundation. Mr. Hill holds a BS in Business Accounting from Brigham Young University and an MBA from Harvard Business School.

“Route 92 Medical is entering a pivotal phase as it scales both operationally and commercially,” said Mitch Hill. “The opportunity to support the leadership team in building out robust financial and strategic infrastructure is compelling, particularly as the company continues to expand access to its technologies globally.”

Mr. Buchanan is an experienced medtech executive and investor with deep expertise in scaling healthcare companies across both operational and strategic roles. Most recently, he was Chief Financial Officer and Chief Operating Officer at Silk Road Medical, where he helped scale the company from inception through its $1.3 billion sale to Boston Scientific. His background includes leadership roles at The Vertical Group, Impax Laboratories, Medtronic, and Ernst & Young. He also serves on the Board of Directors for Aerin Medical, Inc., Procyrion, Inc., and Endologix LLC and is a strategic advisory board member of CRG LP. He holds a BA in Economics from Duke University and an MBA from The Wharton School at the University of Pennsylvania.

“Route 92 Medical has established a strong foundation with its differentiated approach to stroke intervention,” said Lucas Buchanan. “I look forward to contributing to the company’s continued focus on execution, advancing clinical adoption, optimizing reimbursement strategies, and driving disciplined commercial growth.”

“Mitch and Lucas each bring decades of leadership experience across high-growth medtech companies,” said Tony Chou, Chief Executive Officer and Founder at Route 92 Medical. “They understand firsthand the challenges and opportunities that come with scaling innovation in complex healthcare markets, from building the operational backbone needed for sustainable growth to aligning strategy with clinical and commercial execution. Their insights will help strengthen our foundation as we expand access to our technologies and advance the standard of care in neurovascular intervention.”

About Route 92 Medical, Inc.
Route 92 Medical is on a mission to improve outcomes for patients undergoing neurovascular intervention through cutting-edge engineering and innovative product design. Founded by physicians, the company collaborates with leading neurovascular clinicians to solve the biggest challenges in neurointervention and deliver meaningful, differentiated solutions that promote clinical success. For more information, visit www.r92m.com or follow the company on LinkedIn.


Contacts:
For Media
Gwen Gordon
858-245-5684
gwen@gwengordonpr.com

Primary Logo

More News

View More
Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally
Via MarketBeat
Tickers AMZN
Let the Good Times Roll: 2 Stocks Showing No Signs of Slowing
Via MarketBeat
Topics Artificial Intelligence World Trade
Tickers ATRO INOD META
Café Culture Revival? 3 Stocks to Watch After Chick-fil-A’s Move
Via MarketBeat
Tickers CMG MCD SBUX YUM
Carmakers Step in With Incentives as EV Tax Credit Expires
Via MarketBeat
Topics Economy Government
Tickers F GM TSLA
Buy the Dip? Zillow’s Profit Comeback Meets Market Pressure
Via MarketBeat
Topics Lawsuit
Tickers ZG
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.